Company Search:
Advanced Search
Sponsored Links
Arix Bioscience Plc Company Snapshot
Arix Bioscience Plc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Arix Bioscience Plc with three other companies in this sector in UNITED KINGDOM : Shield Therapeutics PLC (2019 sales of £719,000.00 [US$987,639.97 ] of which 100% was Feraccru), Midatech Pharma PLC (£674,000.00 [US$925,826.62 ] of which 100% was Pipeline R&D), and Physiomics PLC (£718,965.00 [US$987,591.89 ] of which 100% was Outsourced Systems and Computational Bio).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Arix Bioscience Plc
  Stock Performance Chart for Arix Bioscience Plc
  Stock Data: Recent Stock Performance:
  Current Price (1/22/2021): 182.50p
(Figures in Pounds Sterling)
1 Week -11.0%   13 Weeks -14.7%  
4 Weeks 69.0%   52 Weeks 90.1%  
Arix Bioscience Plc Key Data:
  Ticker: ARIX Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2019 Sales 506,000
(Year Ending Jan 2020).
Employees: 730
  Currency: Pounds Sterling Market Cap: 247,487,617
  Fiscal Yr Ends: December Shares Outstanding: 135,609,653
  Share Type: Ordinary Closely Held Shares: 39,059,588
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.